Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation

Liver International

Volumn 31, Issue 8, 2011, Pages 1110-1117

  Ten Hove, W Rogier ^a   Korkmaz, Kerem S ^a   op den Dries, Sanna ^b   de Rooij, Bert Jan F ^a   van Hoek, Bart ^a   Porte, Robert J ^b   van der Reijden, Johan J ^a   Coenraad, Minneke J ^a   Dubbeld, Jeroen ^a   Hommes, Daniel W ^a   Verspaget, Hein W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Biliary strictures; Gene polymorphisms; Liver transplantation; Matrix metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B;

ADOLESCENT; ADULT; AGED; ANASTOMOSIS; ARTICLE; BILE DUCT DILATATION; BILE DUCT OBSTRUCTION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DONOR; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GRAFT RECIPIENT; HEPATIC ARTERY; HUMAN; INCIDENCE; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONANASTOMOTIC BILIARY STRICTURE; POSTOPERATIVE PERIOD; RADIODIAGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHOLANGITIS, SCLEROSING; CHOLESTASIS; CONSTRICTION, PATHOLOGIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79961208545     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02459.x     Document Type: Article

References (48)

1. Park JS, Kim MH, Lee SK, et al. Efficacy of endoscopic and percutaneous treatments for biliary complications after cadaveric and living donor liver transplantation. Gastrointest Endosc 2003; 57: 78-85.
2. Qian YB, Liu CL, Lo CM, Fan ST. Risk factors for biliary complications after liver transplantation. Arch Surg 2004; 139: 1101-5.
3. Rerknimitr R, Sherman S, Fogel EL, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc 2002; 55: 224-31.
4. Sawyer RG, Punch JD. Incidence and management of biliary complications after 291 liver transplants following the introduction of transcystic stenting. Transplantation 1998; 66: 1201-7.
5. Thethy S, Thomson BN, Pleass H, et al. Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant 2004; 18: 647-53.
6. Turrion VS, Alvira LG, Jimenez M, et al. Management of the biliary complications associated with liver transplantation: 13 years of experience. Transplant Proc 1999; 31: 2392-3.
7. Guichelaar MM, Benson JT, Malinchoc M, et al. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant 2003; 3: 885-90.
8. Rizk RS, McVicar JP, Emond MJ, et al. Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival. Gastrointest Endosc 1998; 47: 128-35.
9. Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg 2006; 13: 517-24.
10. Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. Am J Roentgenol 1993; 161: 297-300.
11. Distante V, Farouk M, Kurzawinski TR, et al. Duct-to-duct biliary reconstruction following liver transplantation for primary sclerosing cholangitis. Transpl Int 1996; 9: 126-30.
12. Feith MP, Klompmaker IJ, Maring JK, et al. Biliary reconstruction during liver transplantation in patients with primary sclerosing cholangitis. Transplant Proc 1997; 29: 560-1.
13. Schmitz V, Neumann UP, Puhl G, et al. Surgical complications and long-term outcome of different biliary reconstructions in liver transplantation for primary sclerosing cholangitis-choledochoduodenostomy versus choledochojejunostomy. Am J Transplant 2006; 6: 379-85.
14. Colonna JO, Shaked A, Gomes AS, et al. Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg 1992; 216: 344-50.
15. Halme L, Hockerstedt K, Lautenschlager I. Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 2003; 75: 1853-8.
16. Kowdley KV, Fawaz KA, Kaplan MM. Extrahepatic biliary stricture associated with cytomegalovirus in a liver transplant recipient. Transpl Int 1996; 9: 161-3.
17. Torras J, Llado L, Figueras J, et al. Biliary tract complications after liver transplantation: type, management, and outcome. Transplant Proc 1999; 31: 2406.
18. Maheshwari A, Maley W, Li Z, Thuluvath PJ. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl 2007; 13: 1645-53.
19. Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010; 97: 744-53.
20. Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology 1994; 191: 735-40.
21. Feller RB, Waugh RC, Selby WS, et al. Biliary strictures after liver transplantation: clinical picture, correlates and outcomes. J Gastroenterol Hepatol 1996; 11: 21-5.
22. Ward EM, Kiely MJ, Maus TP, Wiesner RH, Krom RA. Hilar biliary strictures after liver transplantation: cholangiography and percutaneous treatment. Radiology 1990; 177: 259-63.
23. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology 1993; 17: 605-9.
24. Pascher A, Neuhaus P. Bile duct complications after liver transplantation. Transpl Int 2005; 18: 627-42.
25. Buis CI, Verdonk RC, van der Jagt EJ, et al. Non-anastomotic biliary strictures after adult liver transplantation part one: radiological features and risk factors for early versus late presentation. Liver Transpl 2007; 13: 708-1.
26. Rull R, Garcia Valdecasas JC, Grande L, et al. Intrahepatic biliary lesions after orthotopic liver transplantation. Transpl Int 2001; 14: 129-34.
27. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998; 10: 602-8.
28. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
29. Verspaget HW, Kuyvenhoven JP, Sier CF, van Hoek B. Matrix metalloproteinases in chronic liver disease and liver transplantation. In Lendeckel U, Hooper NM, eds Proteases in Biology and Disease 5: Proteases in Gastrointestinal Tissues. Dordrecht, the Netherlands: Springer, 2006; 209-34.
30. Harendza S, Lovett DH, Panzer U, et al. Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem 2003; 278: 20490-9.
31. Kuyvenhoven JP, van Hoek B, Blom E, et al. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma. Thromb Haemost 2003; 89: 718-25.
32. Price SJ, Greaves DR, Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001; 276: 7549-58.
33. Miao X, Yu C, Tan W, et al. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 2003; 63: 3987-90.
34. Wu J, Zhang L, Luo H, et al. Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma. DNA Cell Biol 2008; 27: 553-7.
35. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99: 1788-94.
36. Ten Hove WR, de Rooij BJF, van Hoek B, et al. MMP-2 and MMP-9 serum levels change but their gene promotor polymorphisms are not associated with late phase I/R injury or rejection after orthotopic liver transplantation. Open Transplant Journal 2008; 2: 66-72.
37. Zhou LM, Wang L, Palais R, Pryor R, Wittwer CT. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 2005; 51: 1770-7.
38. Kubben FJ, Sier CF, Meijer MJ, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 2006; 95: 744-51.
39. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88-8.
40. Meijer MJ, Mieremet-Ooms MA, van Hogezand RA, et al. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 2007; 13: 2960-6.
41. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992; 16: 49-53.
42. Buis CI, Geuken E, Visser DS, et al. Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol 2009; 50: 69-79.
43. Geuken E, Visser D, Kuipers F, et al. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol 2004; 41: 1017-25.
44. Milani S, Herbst H, Schuppan D, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994; 144: 528-37.
45. Kuyvenhoven JP, Verspaget HW, Gao Q, et al. Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection. Transplantation 2004; 77: 1646-52.
46. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21: 373-84.
47. Sankary HN, McChesney L, Hart M, Foster P, Williams J. Identification of donor and recipient risk factors associated with nonanastomotic biliary strictures in human hepatic allografts. Transplant Proc 1993; 25: 1964-7.
48. Brandsaeter B, Schrumpf E, Bentdal O, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005; 11: 1361-9.